Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

Amgen (AMGN) Stock Price Prediction and News Highlight
Fri. Apr 4, 2025

Amgen is making significant strides in drug development, particularly in the realm of rare autoimmune diseases, as demonstrated by the approval of UPLIZNA, a breakthrough therapy. The company's commitment to innovative product development is further underscored by its advancements in therapies aimed at obesity. The focus on creating effective treatment solutions for serious health conditions illustrates a strong potential for future growth. However, challenges in regulatory approval processes and market competition could impact the pace of these developments.

The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for AMGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.7, and the negative at -0.2 on 2025-04-04. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (4.1) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

AMGN
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-04-040%(0%)    0    0%    0.5          4.1    -1   
2025-04-030%(0%)    0    0%    0.5          4    -1   
2025-04-020%(0%)    0    0%    0.3          2.6    -1   
2025-04-010%(0%)    0    0%    0.3          2.5    -1   
2025-03-310%(0%)    0    0%    0.2          2.4    -1   
2025-03-280%(0%)    0    0%    -0.2          -0.2    -1   
2025-03-270%(0%)    0    0%    -0.2          -0.2    -1   
2025-03-260%(0%)    0    0%    -0.2          -0.2    -1   
2025-03-250%(0%)    0    0%    -0.2          0    -1   
2025-03-240%(0%)    0    0%    -0          0.9    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-07-18 17:48:16 Amgen's leadership in developing innovative treatments reinforces its role as a frontrunner in the pharmaceutical industry.
2025-07-18 17:48:16 The introduction of Uplizna positively impacts patient care and treatment options within the growing market for rare diseases.
2025-07-18 17:48:16 Uplizna's designation as the first and only treatment for a specific condition enhances Amgen's competitive position in the pharmaceutical market.
2025-07-18 17:48:16 The development of Uplizna as a treatment for immunoglobulin G4-related disease highlights advancements in drug development for rare autoimmune diseases.
2025-07-18 17:48:16 The approval of Amgen's Uplizna by the FDA signifies a positive regulatory impact on the company's product offerings and market position.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA